Efficacy of rociletinib (CO-1686) in plasma-genotyped T790M-positive non-small cell lung cancer (NSCLC) patients (pts). Sequist, L. V., Goldman, J., Wakelee, H. A., Camidge, D., Yu, H., Varga, A., Solomon, B., Oxnard, G. R., Ou, S., Papadimitrakopoulou, V., Chao, B. H., Liu, S. V., Reckamp, K. L., Spira, A. I., Piotrowska, Z., Despain, D., Karlovich, C., Yurasov, S., Soria, J. AMER SOC CLINICAL ONCOLOGY. 2015

View details for Web of Science ID 000358036901714